Symbol
|
ZMFLTQ | ZKYLTQ | RNOAPV | RNOAAV | RNOAJV | RNOALV | COMBKB |
---|---|---|---|---|---|---|---|
Nom | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible |
Sous-jacent
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket | Novo Nordisk AS (B) | Novo Nordisk AS (B) | Novo Nordisk AS (B) | Novo Nordisk AS (B) | Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
08.10.2025 | 22.03.2027 | 07.08.2025 | 18.08.2025 | 15.09.2025 | 05.01.2026 | 24.08.2026 |
Ratio | - | 0,9055 | 0,912001 | 0,867498 | 0,894398 | 0,589501 | - |
Prix d'exercise
|
- | - | - | - | - | - | - |
rendement max. p.a. | - | 37,20% | - | - | - | 37,64% | 21,82% |
Demande | 56,12 | 66,49 | 49,100 | 51,20 | 49,700 | 83,50 | 90,00 |
Offre | - | 67,16 | - | - | - | 84,30 | 90,80 |